Tumor ablation needle with independently activated and...

Surgery – Instruments – Electrical application

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C607S101000

Reexamination Certificate

active

07025767

ABSTRACT:
The present invention relates to an apparatus and method for utilizing energy, such as radio frequency (RF) energy, to treat defined areas of tissue and more particularly to ablate tumors with RF energy through the use of a needle having a spreading array of individually traversing conductive tines which are independently positioned and activated.

REFERENCES:
patent: 5370675 (1994-12-01), Edwards et al.
patent: 5536267 (1996-07-01), Edwards et al.
patent: 5672173 (1997-09-01), Gough et al.
patent: 5672174 (1997-09-01), Gough et al.
patent: 5728143 (1998-03-01), Gough et al.
patent: 5741225 (1998-04-01), Lax et al.
patent: 5766153 (1998-06-01), Eggers et al.
patent: 5782827 (1998-07-01), Gough et al.
patent: 5800484 (1998-09-01), Gough et al.
patent: 5810804 (1998-09-01), Gough et al.
patent: 5827276 (1998-10-01), LeVeen et al.
patent: 5855576 (1999-01-01), LeVeen et al.
patent: 5863290 (1999-01-01), Gough et al.
patent: 5868740 (1999-02-01), LeVeen et al.
patent: 5913855 (1999-06-01), Gough et al.
patent: 5925042 (1999-07-01), Gough et al.
patent: 5928229 (1999-07-01), Gough et al.
patent: 5935123 (1999-08-01), Edwards et al.
patent: 5951547 (1999-09-01), Gough et al.
patent: 5954717 (1999-09-01), Behl et al.
patent: 5980517 (1999-11-01), Gough et al.
patent: 6041260 (2000-03-01), Stern et al.
patent: 6050992 (2000-04-01), Nichols
patent: 6053937 (2000-04-01), Edwards et al.
patent: 6059780 (2000-05-01), Gough et al.
patent: 6071280 (2000-06-01), Edwards et al.
patent: 6077261 (2000-06-01), Behl et al.
patent: 6080149 (2000-06-01), Huang et al.
patent: 6080150 (2000-06-01), Gough
patent: 6090105 (2000-07-01), Zepeda et al.
patent: 6235023 (2001-05-01), Lee et al.
Radiotherapeutics Corporation, “Radiofrequency Energy: Clinical Applications—Previously presented data from experiences with the RF 2000™ Generator and the LeVeen™ Needle Electrode” 1. Abstract:Soulen, et al.,“Oral Presentation at the SCVIR,” Mar. 20-15, 1999, inRadiofrequency Energy: Clinical Applications, Radio Therapeutics Corporation.
Radiotherapeutics Corporation, “Radiofrequency Energy: Clinical Applications—Previously presented data from experiences with the RF 2000 ™ Generator and the LeVeen™ Needle electrode” 2. Abstract: Bauer, et al., “Radiofrequency Ablation Therapy for Large, Complex Hepatic Metastases,” 52ndAnnual Mtg. Of Society of Surgical Oncologists, Mar. 4-7, 1999, inRadiofrequency Energy: Clinical Applications, Radio Therapuetics Corporation.
Radiotherapeutics Corporation, “Radiofrequency Energy: Clinical Applications—Previously presented data from experiences with the RF 2000™ Generator and the LeVeen™ Needle Electrode” 3. Abstract: Birdwell, et al., “Preliminary Experience with Intraoperative Radiofrequency Breast Tumor Ablation,” 84thAnnual Mfg. Of the Radiology Society of North America, Nov. 29-Dec. 4, 1998 inRadiofrequency Energy: Clinical Applications, Radio Therapeutics Corporation.
Radiotherapeutics Corporation, “Radiofrequency Energy: Clinical Applications—Previously presented data from experiences with the RF2000™ Generator and the LeVeen™ Needle Electrode” 4. Abstract: Curley, et al., “Freeze or Fry: A Comparison of Cryoablation and Radiofrequency Ablation for Malignant Liver Tumors,” 49thAnnual Mtg. Of the American Association for the Study of Liver Diseases, Nov. 6-Nov. 10, 1998 inRadiofrequency Energy: Clinical Applications, Radio Therapeutics Corporation.
Radiotherapeutics Corporation, “Radiofrequency Energy: Clinical Applications—Previously presented data from experiences with the RF2000™ Generator and the LeVeen™ Needle Electrode” 5. Abwstract: Gantert et al., “Radiofrequency Ablation of Malignant Liver Tumors: Development of a New Multi-Array Electrode and Results of the First Human Treat-and-Resect Trials,” 51stAnnual Mtg. Of the Society of Surgical Oncologists, Mar.26-Mar. 29, 1998 inRadiofrequency Energy: Clinical Applications, Radio Therapeutics Corporation.
Radiotherapeutics Corporation, “Radiofrequency Energy: Clinical Applications—Previously presented data from experiences with the RF2000™ Generator and the LeVeen™ Needle Electrode” 6. Abstract: Gandhi et al., “MR-Guided radio Frequency Ablation of Breast Tissue Preliminary Results in a Mixed Fat-Water Tissue Phantom,” 23rdAnnual Mtg. Of the Society of Cardiovascular & Interventional Radiologists, Feb. 28-Mar. 5, 1998.
Radiotherapeutics Corporation, “Radiofrequency Energy: Clinical Applications—Previously presented data from experiences with the RF2000™ Generator and the LeVeen™ Needle Electrode” 7. Abstract: LeVeen et al., “Large RF Ablation Lesion Produced with a Radially Expanding Monopolar Array Electrode: Long-term Porcine Experiments,” 22ndAnnual Mtg. Of Society of Cardiovascular & Interventional Radiology, Mar. 8-13, 1997.
Radiotherapeutics Corporation, “Radiofrequency Energy: Clinical Applications—Previously presented data from experience with the RF2000™ Generator and the LeVeem™ Needle Electrode” 8. Abstract: LeVeen et al., “Large Volume Porcine Liver Ablation with Use of a Percutaneous Expandable Electrosurgical Probe,” 21stAnnual Mtg. Of Society of Cardiovascular & Interventional Radiology, 03-27-3-7, 1996.
Radiotherapeutics Corporation, “Radiofrequency Energy: Clinical Applications—Previously presented data from experiences with the RF2000™ Generator and the LeVeen™ Needle Electrode” 9. Curley, “Case Study: Radiofrequency-induced necrosis of liver tissue—Nectoris zones 1 and 6 months after the procedure,”.
Curley, “Radiofrequency Ablation of Unresectable Primary and Metastatic Hepatic Malignancies”, Anals of Surgery, pp 1-8: 130(1), 1999.
Lawson, “Radiofrequency-induced Necrosis in Soft Tissues, A review of Deployments in Animals and Humans,”
Lawson, “Radiofrequeny-induced Necrosis in Soft Tissues, A Result from Animal and Human Deployments,” Radio Therapeutics Corporation.
LeVeen, “Laser Hyperthermia and Radiofrequency Ablation of Hepatic Lesions,” Seminars in Interventional Radiology, pp 313-324: 14 (3), 1997.
RTC Training Manual, Chapters 1-9.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Tumor ablation needle with independently activated and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tumor ablation needle with independently activated and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tumor ablation needle with independently activated and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3621862

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.